Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-06-27 2019-08-21 87684
RATIO-IPRA SAL UDV 0.5MG 2.5MG SOLUTION Resolved 2019-07-02 2019-07-16 88167
FLUDARABINE PHOSPHATE FOR INJECTION 25MG SOLUTION Resolved 2019-08-06 2019-11-19 90935
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2019-08-22 2019-10-24 92180
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-08-22 2019-10-10 92198
ACT LATANOPROST/TIMOLOL 5MG 50MCG SOLUTION Resolved 2019-08-22 2019-10-24 92229
TEVA-LATANOPROST 0.05MG SOLUTION Resolved 2019-09-05 2020-07-10 93159
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-09-12 2019-11-22 93650
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-09-26 2019-11-14 94840
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95373
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-11-01 95381
ACT PROGESTERONE INJECTION 50MG SOLUTION Resolved 2019-10-24 2020-05-14 97147
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-02-21 98179
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-01-27 98185
CISPLATIN INJECTION 1.0MG SOLUTION Resolved 2019-11-07 2020-05-29 98188
FLUDARABINE PHOSPHATE FOR INJECTION 25MG SOLUTION Resolved 2019-11-21 2020-01-09 99441
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-28 2020-06-25 99955
TEVA-COMBO STERINEBS 0.5MG 2.5MG SOLUTION Resolved 2019-12-19 2020-09-03 101702
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-01-09 2020-02-21 102893

Showing 721 to 740 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT NABILONE 1MG CAPSULE Discontinued 2019-10-31 2019-11-01 97581
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
TEVA-QUININE 300MG CAPSULE Discontinued 2020-01-24 2020-01-24 104294
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-PREGABALIN 75MG CAPSULE Discontinued 2020-07-10 2020-07-10 120033
ACT CELECOXIB 100MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123648
ACT CELECOXIB 200MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123651
TEVA-QUININE 200MG CAPSULE Discontinued 2020-10-08 2020-10-09 125976
TEVA-CEPHALEXIN 500MG CAPSULE Discontinued 2020-10-08 2020-10-09 125979
ACT NABILONE 0.5MG CAPSULE Discontinued 2020-10-15 2020-10-15 126452
ACT CELECOXIB 200MG CAPSULE Discontinued 2021-02-12 2021-02-12 133874
ACT CELECOXIB 100MG CAPSULE Discontinued 2021-02-12 2021-02-12 133880
ACT NABILONE 0.5MG CAPSULE Discontinued 2021-09-23 2021-09-23 146066
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117491
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117494
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65292
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65295

Showing 41 to 60 of 250